Despite being produced mostly by adipocytes, circulating adiponectin is inversely correlated with BMI, and its levels are decreased in conditions defined as metabolic risk factors for AD, such as insulin resistance, type 2 diabetes mellitus (T2DM), obesity, hypertension, and cardiovascular diseases [21,22]. This evidence concerns the gene ADIPOQ and Alzheimer disease.